Long-term survival after pancreaticoduodenectomy for duodenal papillary adenocarcinoma in a patient with acquired immunodeficiency syndrome: A case report and review of literature
World Journal of Gastrointestinal Surgery · 27.07.2026 · 18 (7)
DOI: 10.4240/wjgs.117966 ↗Kurz gefasst
Fallbericht in der Zeitschrift World Journal of Gastrointestinal Surgery, online erschienen am 27.07.2026. Verfasst von Kang-Ning Li und 4 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Duodenal papillary adenocarcinoma is exceptionally rare in patients with acquired immunodeficiency syndrome (AIDS), and while this would normally be treated by radical resection, such treatment has historically been considered high-risk in AIDS patients due to their immune deficiencies. CASE SUMMARY This report presents the case of a 63-year-old female with AIDS who underwent pancreaticoduodenectomy for duodenal papillary adenocarcinoma (pT2N1M0, stage IIIA) and achieved 5-year survival. Through standardized antiretroviral therapy, her CD4+ levels were maintained above 200 cells/μL. Perioperative infection prophylaxis included piperacillin-tazobactam and ornidazole. Postoperative adjuvant chemotherapy was initiated based on her absolute neutrophil count being ≥ 1.50 × 109/L but was reduced due to the occurrence of recurrent grade 3 diarrhea; ultimately, the patient could tolerate only 70% of the standard XELOX regimen over four cycles. The surgery was completed without complications. During over 5 years of follow-up, surveillance imaging showed no recurrence or metastasis, the tumor markers remained normal, and her performance status was fully recovered. CONCLUSION This case demonstrates that with immune optimization (CD4+ > 200 cells/μL), tailored infection prophylaxis, and neutrophil-guided chemotherapy, radical surgery can be feasible and can enable long-term survival in AIDS patients with duodenal papillary adenocarcinoma, suggesting that the CD4+ level is a potential threshold for assessing patient eligibility for surgery in comparable cases.
Zitieren
APA
Li, K., Chen, Q., Huang, C., Liu, T., & Li, H. (2026). Long-term survival after pancreaticoduodenectomy for duodenal papillary adenocarcinoma in a patient with acquired immunodeficiency syndrome: A case report and review of literature. World Journal of Gastrointestinal Surgery, 18(7). https://doi.org/10.4240/wjgs.117966
Vancouver
Li K, Chen Q, Huang C, Liu T, Li H. Long-term survival after pancreaticoduodenectomy for duodenal papillary adenocarcinoma in a patient with acquired immunodeficiency syndrome: A case report and review of literature. World Journal of Gastrointestinal Surgery. 2026;18(7). doi:10.4240/wjgs.117966
BibTeX
@article{Li2026,
author = {Li, Kang-Ning and Chen, Qing and Huang, Chun-Tao and Liu, Tian-Qi and Li, Hong-Fei},
title = {Long-term survival after pancreaticoduodenectomy for duodenal papillary adenocarcinoma in a patient with acquired immunodeficiency syndrome: A case report and review of literature},
journal = {World Journal of Gastrointestinal Surgery},
year = {2026},
volume = {18},
number = {7},
doi = {10.4240/wjgs.117966}
}
EUVIMED